Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19)
Clinical trial NCT04480138 · TERMINATED
Trial details
- NCT number
- NCT04480138
- Sponsor
- Zydus Lifesciences Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2021-06-21
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.